Angiosarcoma of the liver as a cause of fulminant liver failure
- Marco Montell García1,
- Raúl Romero Cabello1,2,
- Raul Romero Feregrino3,
- Mercado Atri Moises4,
- Rafael Trejo Estrada5,
- Padilla-Rodríguez Alvaro6,7,
- Gama Moreno Manlio Gerardo8,
- Romero Feregrino Rodrigo3
- 1Department of Infectology, Hospital General de México, Mexico City, Mexico D F, Mexico
- 2Department of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autónoma de México
- 3Department of Infectology, Instituto para el Desarrollo Integral de la Salud (IDISA), Mexico City, Mexico D F, Mexico
- 4Endocrinology, Centro Médico ABC, México
- 5Gastroenterology, Centro Médico ABC, México DF, México
- 6Departament of Pathology, Centro Médico ABC, México DF, México
- 7Departament of Pathology, Universidad Panamericana, México
- 8Departament of Nuclear Medicine, Centro Médico ABC, México
- Correspondence to Dr Raul Romero Feregrino, drraulromeroferegrino{at}hotmail.com
Primary liver sarcomas make up 2% of all malignant neoplasms of the liver; of these, angiosarcoma is the most common type. Primary liver tumours rarely cause fulminant hepatic failure (FHF), which is most frequently caused by non-neoplasmic pathologies. In the case of neoplasms, the most frequent are lymphoma and metastatic carcinomas. We describe the case of a 76-year-old man who suffered from FHF as a result of a liver angiosarcoma and we present a review of the medical literature in which we found only two cases of liver angiosarcomas linked to FHF.
